Poster Session > Session
Online Poster Session
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
THE ROLE OF FIBRINOGEN IN CHANGING THE HEMOSTASIS OF PATIENTS WITH NEOPLASIA AND THEIR INFLUENCE ON THE MICROCIRCULATORY BED OF THE LUNGS AND CONTROL BY ANTICOAGULANTS Vira A. Barilka, Volodymyr L. Matlan, Sofia V. Prymak, Olha O. Shalay, Vasyl L. Novak. SI "Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine" Lviv Ukraine, Lviv, Ukrenia |
|||||
|
ANTITHROMBOTIC STEWARDSHIP AND HEALTH EQUITY IN PERIPHERAL ARTERY DISEASE Kelly M. Rudd1,2, Kristie K. Roberts1, Cooper M. Hamilton2. 1Oklahoma State University Center for Health Sciences Center College of Osteopathic Medicine, Tulsa, OK, USA 2Oklahoma State University Center for Health Sciences Center College of Osteopathic Medicine, Tahlequah, OK, USA |
||||
A2. PLATELET ACTIVATION AND BIOCHEMISTRY | |||||
|
PLATELET IMMUNOPHENOTYPE INDUCED BY THE SPIKE (S) PROTEIN AND THE RBD DOMAIN OF SARS-COV-2 VIRUS. Alan Cano-Mendez, Nallely Garcia-Larragoiti, Yesenia Ambriz-Murillo, Patricia Guzman-Cansino, Alejandra Ochoa-Zarzosa, Martha Eva Viveros-Sandoval. Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico |
|||||
A3. VASCULAR WALL BIOLOGY, ENDOTHELIAL PROGENITOR CELLS AND PLATELET ADHESION | |||||
|
CORRELATION BETWEEN ABO BLOOD TYPES AND DISEASE SEVERITY IN SICKLE CELL ANEMIA: IMPLICATIONS FOR THROMBOSIS AND HEMOSTASIS. George M Bassey1, Titilope A Adeyemo1,2, Ann A Ogbenna1,2, Abiola B Bolarinwa1, Ademola S Adewoyin2, Emmanuel Iyere1. 1Lagos University Teaching Hospital, Lagos, Nigeria 2College of Medicine University of Lagos, Lagos, Nigeria |
||||
A4. DISORDERS OF PLATELET NUMBER OR FUNCTION | |||||
|
THE PREVALENCE OF THROMBOTIC EVENTS REPORTED FOLLOWING SARS-COV2 VACCINE RECEIPT: DATA FROM THE ITP NATURAL HISTORY STUDY REGISTRY Jennifer DiRaimo1, Caroline Kruse1, Kate Foster1, Alexandra Kruse1,2, Howard Liebman3, Craig Kessler4. 1Platelet Disorder Support Association, Cleveland, OH, USA 2Tulane University School of Medicine, New Orleans, LA, USA 3Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Norris Comprehensive Cancer Center, Los Angeles, CA, USA 4Vincent Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA |
||||
A5. BLOOD COAGULATION AND FIBRINOLYTIC FACTORS | |||||
|
INVESTIGATING INTER-ASSAY VARIABILITY BETWEEN DOAC CALIBRATED ANTI-FACTOR XA ASSAYS: A SUBSTUDY OF THE PAUSE TRIAL Ryan Baker1, Rita Selby2,3, Karen A. Moffat4,5, Melanie St John5, Alex C. Spyropoulos6,7,8, Sam Schulman9, James Douketis9. 1Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada 2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada 3Department of Medicine, University of Toronto, Toronto, ON, Canada 4Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada 5Department of Medicine, McMaster University, Hamilton, ON, Canada 6The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA 7Institute of Health System Science - The Feinstein Institutes for Medical Research, Manhasset, NY, USA 8Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY, USA 9Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada |
||||
|
CHIEF: A RETROSPECTIVE SELF-CONTROL STUDY OF CHILDREN <12 WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS COMPARING EMICIZUMAB TO FVIII Daniel Mashiach1,2, Patrice Mead1, Kendall Carneiro1, Jemily Malvar1, Guy Young1,3. 1Children’s Hospital Los Angeles, Los Angeles, CA, USA 2WesternU College of Osteopathic Medicine of the Pacific, Pomona, CA, USA 3Keck School of Medicine, University of Southern California, Los Angeles, CA, USA |
||||
|
THE EVALUATION OF MRX PT DOAC ASSAY FOR DETECTION OF CLINICALLY RELEVANT FACTOR XA INHIBITOR DRUG LEVELS Brittany MA Salter1, Karen A Moffat1,2,3, Stephen A Carlino3, Liselotte Onelöv4, Sarah Ge1, Marina Atalla1, Raymond Melika1, Saumya Bansal1, Siraj Mithoowani1, Mark Crowther1,2. 1Department of Medicine, McMaster University, Hamilton, ON, Canada 2Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada 3Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada 4Nordic Biomarker, Umeå, Sweden |
||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
A RETROSPECTIVE STUDY OF ACQUIRED VON WILLEBRAND SYNDROME IN MYELOPROLIFERATIVE NEOPLASMS Mohammed Al Sharif 1,2, Brian Harnett 3, Subia Tasneem 1, Brian Leber 4,5, Christopher Hillis 5, Catherine P.M. Hayward 1,3,4. 1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada 2 Department of Pathology and Laboratory Medicine, King Abdullah Bin Abdulaziz University Hospital, Princess Nourah University, Riyadh, Saudi Arabia 3 Department of Medicine, McMaster University, Hamilton, ON, Canada 4 Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada 5 Hematology/Oncology, Juravinski Cancer Center, Hamilton, ON, Canada |
||||
|
DEVELOPMENT OF A PATIENT REPORTED OUTCOME MEASURE TO STUDY QUALITY OF LIFE IN BLEEDING DISORDER OF UNKNOWN CAUSE Callie Berkowitz1, Supreet Goraya2, Alice Ma1, Nigel Key1, Angela Stover3. 1Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, NC, USA 2Department of Maternal, Child, and Family Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA 3Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA |
||||
|
USING A THROMBODYNAMICS TEST FOR DIAGNOSTICS OF HYPERCOAGULATION IN CANCER PATIENTS AND PREDICTION OF THROMBOEMBOLIC COMPLICATIONS: PRELIMINARY RESEARCH RESULTS. Irina Dudina1, Ekaterina Koltsova2,3, Irina Nigmatullina1, Yana Akhmadiyarova1, Olga Kostash1, Anna Chankina1, Daniil Stroyakovskiy1. 1State Budgetary Healthcare Institution Moscow City Oncology Hospital No. 62 of the Moscow City Health Department, Russian Federation, Moscow, 143515, Moskovskaya area, Krasnogorsk urban district, Istra village, building 27, Moscow, Russia 2Federal State Budgetary Institution Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Health of the Russian Federation, Russian Federation, Moscow, 117198, Samory Machel street, building 1, Moscow, Russia 3Federal State Budgetary Institution of Science Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Moscow, 109029, Srednyaya Kalitnikovskaya street, building 30, Moscow, Russia |
||||
|
COMPARATIVE ANALYSIS OF BLEEDING AND THROMBOTIC RISKS AMONG IMMUNE CHECKPOINT INHIBITORS: INSIGHTS FROM THE FDA ADVERSE EVENT REPORTING SYSTEM Emily L Paton1, Emma P Deloughery1,2. 1Oregon Health & Science University, Department of Medicine, Portland, OR, USA 2Oregon Health & Science University, Department of Medicine, Division of Hematology & Medical Oncology, Portland, OR, USA |
||||
|
ACQUIRED HEMOPHILIA SECONDARY TO THE TRANSPLANTATION OF HEMATOPOIETIC PROGENITORS. A SYSTEMATIC REVIEW Rafael Pichardo-Rodriguez1, Cristhian Gonzales- Rospigliosi1, Dalia Pimentel-Ramirez1, Aracely Carrasco-Espinoza1, Lara Vela-Rojas1, Diana-Cristina Ramírez-Meyhuay1, Jhony A. De La Cruz-Vargas1, Alfredo Wong Chang2, Cristobal Frutos3. 1Instituto de Investigaciones en Ciencias Biomédicas (INICIB). Universidad Ricardo Palma, Lima, Peru 2Unidad de Trasplante de Médula Ósea. Hospital Nacional Edgardo Rebagliati-Essalud, Lima, Peru 3Instituto de Previsión Social, Asuncion, Paraguay |
|||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
EFFECT OF ACUTE DEEP VEIN THROMBOSIS IN PATIENTS WITH LUNG CANCER IN ACUTE DEEP VEIN THROMBOSIS (DVT): A STUDY OF THE NATION INPATIENT SAMPLE Maria Cristina Cuartas- Mesa, Nana Yaa Ampaw, Edwin Gwira- Tamattey, Enrique Martinez- Trevino, Alejandro Nieto- Dominguez , Ekrem Turk . John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA |
|||||
|
GATHERING AND DISSEMINATING STANDARDIZED GENE THERAPY DATA - THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY Barbara A. Konkle1, Flora Peyvandi2, Mayss Naccache3, Wolfgang Miesbach4, Brian O'Mahony5, Steven W. Pipe6, Mark W. Skinner7, Donna Coffin3, Glenn F. Pierce3. 1University of Washington, Seattle, WA, USA 2Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy 3World Federation of Hemophilia, Montreal, QC, Canada 4University Hospital Frankfurt, Frankfurt, Germany 5Irish Haemophilia Society, Dublin, Ireland 6University of Michigan, Ann Arbor, MI, USA 7Institute for Policy Advancement Ltd, Washington, DC, USA |
||||
|
PREDICTING PULMONARY EMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS IN THE EMERGENCY DEPARTMENT: A QUANTITATIVE D-DIMER DIAGNOSTIC APPROACH FROM A HOSPITAL IN MEXICO CITY Oscar A Lopez Ramos1, David G Gonzalez Sanchez 2, Oliver A Gomez-Gutierrex2, Hector Segura Marin2, Andrea Rojas Guevara 1, Arely Gayosso Godinez 1. 1Hospital Español, Mexico City, Mexico 2Tecnologico de Monterrey, Monterrey, Mexico |
||||